This specific ISBN edition is currently not available.View all copies of this ISBN edition:
The recent development of drugs that selectively antagonize cardiovascular AII receptors allows a pharmacological management strategy for hypertension which is a relatively free of both metabolic and subjective side-effects. Eprosartan is one such drug and allows this strategy to be implemented with a simple, once-daily dosing schedule.
"synopsis" may belong to another edition of this title.
Book Description Royal Society of Medicine Press Ltd. Condition: Like New. Used - Like New. Seller Inventory # Z1-T-018-00574